| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 3.867 | 2.838 | 1.780 | 716 | 19.341 | 53.672 | 59.957 | 45.309 | 16.875 |
| Total Income - EUR | 0 | 3.867 | 2.838 | 1.780 | 716 | 19.341 | 53.672 | 59.957 | 45.309 | 23.386 |
| Total Expenses - EUR | 0 | 4.196 | 2.429 | 3.442 | 1.871 | 18.782 | 51.038 | 58.751 | 43.376 | 23.001 |
| Gross Profit/Loss - EUR | 0 | -329 | 409 | -1.662 | -1.154 | 559 | 2.634 | 1.205 | 1.933 | 385 |
| Net Profit/Loss - EUR | 0 | -445 | 324 | -1.716 | -1.176 | 439 | 2.097 | 606 | 1.489 | 186 |
| Employees | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Emi Teomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 269 | 122 | 914 | 634 | 362 | 103 | 8 | 8 | 8 | 8 |
| Current Assets | 510 | 1.826 | 400 | 479 | 78 | 5.003 | 8.000 | 6.240 | 4.433 | 3.078 |
| Inventories | 375 | 1.729 | 321 | 315 | 0 | 4.921 | 7.733 | 4.867 | 3.387 | 2.209 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 550 | 354 | 754 |
| Cash | 135 | 97 | 80 | 164 | 78 | 83 | 267 | 823 | 692 | 115 |
| Shareholders Funds | 45 | -400 | -1.448 | -3.137 | -4.252 | -3.732 | -1.553 | -952 | 540 | 723 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 957 | 2.486 | 2.899 | 4.383 | 4.692 | 8.839 | 9.561 | 7.200 | 3.901 | 2.363 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4939 - 4939" | |||||||||
| CAEN Financial Year |
4939
|
|||||||||
Comments - Emi Teomed S.r.l.